Anti-malaria drug hydroxychloroquine’s coronavirus trials to resume: WHO

The World Health Organization on Wednesday said that clinical trials of the anti-malaria drug hydroxychloroquine will resume, having been suspended pending a safety review in the search for coronavirus treatments.

“On the basis of the available mortality data… the executive group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm,” WHO Chief Tedros Adhanom Ghebreyesus told a virtual news briefing.

ALSO READ: COVID-19 Explainer: Nations that have successfully flattened the virus curve

Click here for Latest News updates and viral videos on our AI-powered smart news

For viral videos and Latest trends subscribe to NewsMobile YouTube Channel and Follow us on Instagram

LEAVE A REPLY

Please enter your comment!
Please enter your name here